Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides
Authors
Keywords
-
Journal
EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 239, Issue 8, Pages 1025-1035
Publisher
SAGE Publications
Online
2014-04-17
DOI
10.1177/1535370214530247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role and function of macrophages in the metabolic syndrome
- (2012) Prerna Bhargava et al. BIOCHEMICAL JOURNAL
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
- (2012) Geoffrey C. Farrell et al. Gut and Liver
- Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats
- (2012) Anna Alisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
- (2011) Veerle Bieghs et al. ATHEROSCLEROSIS
- Emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons
- (2011) J-D Xu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emodin, a natural product, selectively inhibits 11β-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice
- (2010) Ying Feng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells
- (2010) Guoquan Meng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Non-alcoholic fatty liver disease from pathogenesis to management: an update
- (2009) G. Musso et al. Obesity Reviews
- Effects of emodin on the gene expression profiling of human breast carcinoma cells
- (2009) Zhiwei Huang et al. Cancer Detection and Prevention
- Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice
- (2008) P. D. Cani et al. DIABETES
- Animal models of NASH: Getting both pathology and metabolic context right
- (2008) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Unknown
- (2008) Herbert Tilg et al. MOLECULAR MEDICINE
- Emodin Promotes Atherosclerotic Plaque Stability in Fat-Fed Apolipoprotein E-Deficient Mice
- (2008) Mingxue Zhou et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Visceral adipose tissue area is an independent risk factor for hepatic steatosis
- (2007) Bum J Park et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search